期刊文献+

抗流感病毒药物合成研究纵览 被引量:4

Survey on Anti-Influenza Drug Synthesis
原文传递
导出
摘要 流行性感冒(流感)是一种传染性强和传播速度快的疾病,对人类健康构成严重威胁。为了更好地抵御流感病毒对人类健康的侵害,科学家们一直致力于新型抗流感病毒药物的研究和发现工作。针对已上市抗流感药物以及处于研发阶段的抗流感病毒抑制剂的合成方法进行概述,为抗流感药物的合成工艺研究和药物研发提供参考。 Influenza(flu)is a highly contagious disease that spreads rapidly and poses a serious threat to human health.In order to protect human health and resist the invasion of the flu virus,scientists have been working on the research and discovery of new anti-influenza drugs.This review focuses on the synthesis of anti-influenza virus drugs that have been marketed and anti-influenza inhibitors at the development stage.It also provides reference for synthetic process research and novel anti-influenza drugs development.
作者 蔡岩 丁晓丽 章聚宝 周卫红 苗志伟 CAI Yan;DING Xiao-Li;ZHANG Ju-Bao;ZHOU Wei-Hong;MIAO Zhi-Wei(State Key Laboratory of ElementoTlrganic Chemistry,College of Chemistry,Nankai University,Tianjin 300071,China;College of Chemistry and Environmental Sciences,Kashgar University,Kashgar 844006;College of Life Sciences,Nankai University,Tianjin 300071,China)
出处 《化学教育(中英文)》 CAS 北大核心 2019年第12期5-18,共14页 Chinese Journal of Chemical Education
基金 新疆维吾尔自治区自然科学基金(2016D01A016)
关键词 流行性感冒 流感病毒 抗流感病毒药物 药物合成 influenza influenza virus anti-influenza drugs drug synthesis
  • 相关文献

参考文献6

二级参考文献60

  • 1Furuta Y, Takahashi K, Fukuda Y, et al. In vitro and in vivo activities of anti-influenza virus compound I"-705 [J]. Antimierob Agents Chemother, 2002, 46 (4): 977-981.
  • 2Kiso M, Takahashi K, Sakai-Tagawa Y, et al. To705 (favipiravir) activity against lethal H5N1 influenza A viruses [J]. Proc Natl Aead Sei U S A, 2010, 107 (2) : 882-887.
  • 3Gowen BB, Wong MH, Jung KH, et al. In vitro and in vivo activities of T-705 against arenavirus and bunyavirus infections [J]. Antimierob Agents Chemother, 2007, 51 (9) : 3168-3176.
  • 4Julander JG, Shafer K, Smee DF, et al. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106 [J]. Antimicrob Agents Chemother, 2009, 53 (1): 202-209.
  • 5Furuta Y. Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both: WO, 00/10569 [P]. 2003-03-02.
  • 6Forns P, Esteve C, Taboada L, et al. Pyrazine-based Syk kinase inhibitors [J]. Bioorg Med Chem. Lett, 2012, 22 (8) : 2784-2788.
  • 7Charrier JD, Durrant S J, Golec JM, et al. Discovery of potent and selective inhibitors of ataxia telangiectasia mutated and Rad3 related (ATR) protein kinase as potential anticancer agents [J]. JMed Chem, 2011, 54 (7) : 2320-2330.
  • 8Caldwell J J, Veillard N, Collins I. Design and synthesis of 2 (1H) -pyrazinones as inhibitors of protein kinases [J]. Tetrahedron, 2012, 68 (2012) : 9713-9728.
  • 9Beldar SV, Jordis U. Synthetic studies towards the antiviral pyrazine derivative T-705[C]//13th International Electronic Conference on Synthetic Organic Chemistry, 2009.
  • 10Tamio H. Method for producing dichloropyrazine derivative: WO, 2010/087117 [P]. 2012-08-05.

共引文献38

同被引文献31

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部